Schizophrenia News and Research

Latest Schizophrenia News and Research

Four New York students named National Finalists in Siemens Competition

Months of dedication and hard work in science, technology, engineering and mathematics (STEM) paid off tonight for four students named National Finalists in the Siemens Competition in Math, Science & Technology, the nation's premier research competition.

19 Nov 2012

Induced-pluripotent stem cells not as genetically unstable as previously thought

Stanford University School of Medicine scientists have demonstrated, in a study conducted jointly with researchers at Yale University, that induced-pluripotent stem cells - the embryonic-stem-cell lookalikes whose discovery a few years ago won this year's Nobel Prize in medicine - are not as genetically unstable as was thought.

19 Nov 2012

Two studies investigate role of oxygen in cell transplantation

Two studies published in the current issue of Cell Transplantation, now freely available on-line, investigate the role of oxygen in cell transplantation.

17 Nov 2012

NCCBH now accepts nominations for National Council Awards of Excellence

The National Council for Community Behavioral Healthcare is now accepting nominations for individuals and organizations that qualify to achieve the most prestigious awards in behavioral healthcare — the National Council Awards of Excellence.

17 Nov 2012

Caterpillar fungi may benefit asthma patients

Research shows that cordycepin, extracted from a group of rare parasitic caterpillar fungi of the genus Cordyceps, has unusual anti-inflammatory properties that may make it a good candidate for treating conditions such as asthma and rheumatoid arthritis.

16 Nov 2012

Obstetric complications linked to NSS in schizophrenia

Patients with schizophrenia whose mothers experienced obstetric complications during pregnancy show more neurologic soft signs than those with mothers who did not experience such complications, researchers report.

16 Nov 2012

Study links congenital kidney disease with neurodevelopmental disorders

About 10 percent of kids born with kidney defects have large alterations in their genomes known to be linked with neurodevelopmental delay and mental illness, a new study by Columbia University Medical Center (CUMC) researchers has shown.

16 Nov 2012

White matter alterations evident before psychosis development

Results from a UK study show that white matter integrity is reduced in patients at ultra-high risk for psychosis, although to a lesser extent than in first-episode psychosis patients.

15 Nov 2012

Cannabis withdrawal clinically significant in schizophrenia

Cannabis withdrawal symptoms are clinically significant in schizophrenia patients as they are often associated with behavioral change, say researchers.

15 Nov 2012

AKT1 genotype influences risk of psychotic disorders in cannabis users

The ability of cannabis to produce psychosis has long been an important public health concern. This concern is growing in importance as there is emerging data that cannabis exposure during adolescence may increase the risk of developing schizophrenia, a serious psychotic disorder. Further, with the advent of medical marijuana, a new group of people with uncertain psychosis risk may be exposed to cannabis.

15 Nov 2012

Irregular sleep patterns may trigger schizophrenia symptoms

Neuroscientists studying the link between poor sleep and schizophrenia have found that irregular sleep patterns and desynchronised brain activity during sleep could trigger some of the disease's symptoms. The findings, published in the journal Neuron, suggest that these prolonged disturbances might be a cause and not just a consequence of the disorder's debilitating effects.

15 Nov 2012

Pathway between maternal obesity and childhood asthma nonallergic

Maternal pre-pregnancy bodyweight is associated with the risk for children developing asthma and wheezing by the age of 7 years, Danish research shows.

13 Nov 2012

White matter alterations evident before psychosis development

Results from a UK study show that white matter integrity is reduced in patients at ultra-high risk for psychosis, although to a lesser extent than in first-episode psychosis patients.

13 Nov 2012

Caution over monoclonal antibody treatment for MS

Alemtuzumab, an anti-CD52 monoclonal antibody, provides a more effective treatment for individuals with relapsing‑remitting multiple sclerosis than the immunomodulating drug interferon beta 1a, but has significant side effects, show findings from a phase III trial.

12 Nov 2012